The following anticancer drug has high emetogenic potential
**Core Concept**
Cisplatin is a platinum-based chemotherapy drug used to treat various types of cancers. Its high emetogenic potential is a significant side effect, necessitating prophylactic antiemetic measures. This is due to its mechanism of action, which involves cross-linking DNA, leading to cell death and tumor regression.
**Why the Correct Answer is Right**
Cisplatin's emetogenic potential is attributed to its ability to induce the release of serotonin and other neurotransmitters in the central nervous system, triggering vomiting. This is mediated through the vagus nerve and the chemoreceptor trigger zone in the area postrema. The high incidence of nausea and vomiting associated with cisplatin treatment makes it a significant clinical concern, warranting the use of antiemetic prophylaxis.
**Why Each Wrong Option is Incorrect**
**Option A:** Chlorambucil is an alkylating agent with a relatively low emetogenic potential, making it a less likely choice for high emetogenic potential.
**Option B:** Vincristine is a vinca alkaloid that primarily causes neurotoxicity, such as peripheral neuropathy, rather than emesis.
**Option C:** 6-Mercaptopurine is a purine antimetabolite with a moderate emetogenic potential, but it is not as high as that of cisplatin.
**Clinical Pearl / High-Yield Fact**
When prescribing chemotherapy, it is essential to consider the emetogenic potential of the drug and choose an antiemetic regimen accordingly. Cisplatin's high emetogenic potential highlights the importance of prophylactic antiemetic measures to minimize the risk of chemotherapy-induced nausea and vomiting (CINV).
**✓ Correct Answer: D. Cisplatin**